Attovia Therapeutics, Inc. - 10-Q Filing

Attovia Therapeutics, Inc. reports Q3 financial results including collaboration revenue and ongoing R&D expenditures.

SEC EDGAR ·

Tickers: $ATTO

Read the full article at SEC EDGAR

More Regulatory news